{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:47:54Z","timestamp":1772574474847,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clineuro.2013.08.019","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T17:00:37Z","timestamp":1377622837000},"page":"2358-2361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Use of conivaptan for management of hyponatremia following surgery for Cushing's disease"],"prefix":"10.1016","volume":"115","author":[{"given":"Jonathan D.","family":"Breshears","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan C.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis S.","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2013.08.019_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/pgmj.2008.072819","article-title":"Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients","volume":"85","author":"Sherlock","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-006-9276-2","article-title":"Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution's experience","volume":"9","author":"Adams","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2265.1999.00666.x","article-title":"Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas","volume":"50","author":"Hensen","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e31817b8148","article-title":"Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"337","author":"Annane","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0025","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"91","author":"Ghali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0030","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2146\/ajhp100243","article-title":"Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia","volume":"68","author":"Kalra","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2265.2007.03149.x","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study","volume":"69","author":"Verbalis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jcrc.2012.03.003","article-title":"Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury","volume":"27","author":"Human","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12028-008-9179-3","article-title":"Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit","volume":"11","author":"Murphy","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12028-010-9379-5","article-title":"Use of conivaptan (vaprisol) for hyponatremic neuro-ICU patients","volume":"13","author":"Naidech","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1227\/NEU.0b013e318218c78f","article-title":"Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion","volume":"69","author":"Potts","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-008-9152-1","article-title":"Conivaptan for hyponatremia in the neurocritical care unit","volume":"11","author":"Wright","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ki.2011.78","article-title":"Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet","volume":"80","author":"Gross","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3111\/13696998.2011.643329","article-title":"Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial","volume":"15","author":"Chiong","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.clineuro.2013.08.019_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/hp.2012.02.942","article-title":"Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials","volume":"40","author":"Dasta","year":"2012","journal-title":"Hosp Pract"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846713003223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846713003223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:28:41Z","timestamp":1759588121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846713003223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0303846713003223"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2013.08.019","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of conivaptan for management of hyponatremia following surgery for Cushing's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2013.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}